Zobrazeno 1 - 4
of 4
pro vyhledávání: '"On Behalf Of The MEREAFaPS Study Group"'
Autor:
Giada Crescioli, Ennio Boscia, Alessandra Bettiol, Silvia Pagani, Giulia Spada, Giuditta Violetta Vighi, Roberto Bonaiuti, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, Niccolò Lombardi, on behalf of the MEREAFaPS Study Group
Publikováno v:
Pharmaceuticals, Vol 14, Iss 7, p 678 (2021)
This post hoc analysis of an Italian active pharmacovigilance study describes pharmacological differences of ADEs leading to emergency department (ED) visits and hospitalization in women and men. During the study period (January 2007–December 2018)
Externí odkaz:
https://doaj.org/article/1cc4b65143aa453fa946a238995f6fd2
Autor:
Silvia, Pagani, Niccolò, Lombardi, Giada, Crescioli, Violetta Giuditta, Vighi, Giulia, Spada, Paola, Andreetta, Annalisa, Capuano, Alfredo, Vannacci, Mauro, Venegoni, Giuseppe Danilo, Vighi, On Behalf Of The MEREAFaPS Study Group
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 10; Pages: 2811
The aim of the present study is to describe pharmacological characteristics of drug-related allergies and anaphylaxis leading to the emergency department (ED). An 8-year post hoc analysis on the MEREAFaPS Study database was performed (2012–2019). S
Autor:
Pagani S; Department of Medicine, ASST Vimercate, 20871 Vimercate, Italy., Lombardi N; Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, 50122 Florence, Italy., Crescioli G; Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, 50122 Florence, Italy., Vighi VG; Hospital Pharmacy, ASST Vimercate, 20871 Vimercate, Italy., Spada G; Hospital Pharmacy, ASST Vimercate, 20871 Vimercate, Italy., Andreetta P; Department of Medicine, ASST Vimercate, 20871 Vimercate, Italy., Capuano A; Section of Pharmacology 'L. Donatelli', Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy.; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, 80138 Naples, Italy., Vannacci A; Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, 50122 Florence, Italy., Venegoni M; Department of Medicine, ASST Vimercate, 20871 Vimercate, Italy.; Pharmacology Unit, Department of Diagnostics and Public Health, University of Verona, 37100 Verona, Italy., Vighi GD; Department of Medicine, ASST Vimercate, 20871 Vimercate, Italy., On Behalf Of The MEREAFaPS Study Group
Publikováno v:
Journal of clinical medicine [J Clin Med] 2022 May 16; Vol. 11 (10). Date of Electronic Publication: 2022 May 16.
Autor:
Crescioli G; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, 50139 Florence, Italy.; Tuscan Regional Center of Pharmacovigilance, 50122 Florence, Italy., Boscia E; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, 50139 Florence, Italy., Bettiol A; Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy., Pagani S; Internal Medicine, Medical Department, Vimercate Hospital, ASST di Vimercate, 20871 Vimercate, Italy., Spada G; Internal Medicine, Medical Department, Vimercate Hospital, ASST di Vimercate, 20871 Vimercate, Italy., Vighi GV; Internal Medicine, Medical Department, Vimercate Hospital, ASST di Vimercate, 20871 Vimercate, Italy., Bonaiuti R; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, 50139 Florence, Italy.; Joint Laboratory of Technological Solutions for Clinical Pharmacology, Pharmacovigilance and Bioinformatics, University of Florence, 50139 Florence, Italy., Venegoni M; Pharmacology Unit, Department of Diagnostics and Public Health, University of Verona, 37100 Verona, Italy., Vighi GD; Internal Medicine, Medical Department, Vimercate Hospital, ASST di Vimercate, 20871 Vimercate, Italy., Vannacci A; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, 50139 Florence, Italy.; Tuscan Regional Center of Pharmacovigilance, 50122 Florence, Italy.; Joint Laboratory of Technological Solutions for Clinical Pharmacology, Pharmacovigilance and Bioinformatics, University of Florence, 50139 Florence, Italy., Lombardi N; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, 50139 Florence, Italy.; Tuscan Regional Center of Pharmacovigilance, 50122 Florence, Italy., On Behalf Of The MEREAFaPS Study Group
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Jul 15; Vol. 14 (7). Date of Electronic Publication: 2021 Jul 15.